Awards and Rankings
March 24, 2023

The American Lawyer Names Lisa Haddad and Stuart Cable 2023 Dealmakers of the Year

The American Lawyer has named Goodwin partners Lisa Haddad and Stuart Cable 2023 Dealmakers of the Year for their work advising Citrix on its acquisition by affiliates of Vista Equity Partners and Evergreen Coast Capital for $16.5 billion. The prestigious annual awards program honors lawyers who have led the most complex, impactful deals of the last year.

The American Lawyer praised Haddad and Cable’s ability to navigate “a growing array of global regulations and a volatile credit market” throughout this deal. The publication stated that they repeatedly “answered the call” in order to “craft one of the largest private equity-backed-acquisitions of a software company in history.”

Haddad is co-chair of Goodwin’s Public M&A / Corporate Governance practice, where she focuses on mergers and acquisitions, corporate governance, securities offerings, securities law compliance for public companies, and general corporate matters. She has routinely been recognized for excellence in M&A and Corporate Governance by Chambers USA, The Legal 500 United States, and IFLR1000, and has been named to The Deal’s Top Women in Dealmaking.

Cable serves as Goodwin’s Vice Chairman and Global Chair of M&A, and is a trusted advisor to a number of world’s most innovative technology and life sciences companies. Over the course of his career, Cable has been named Corporate Attorney of the Year by LMG Life Sciences and a Law360 MVP for Life Sciences. Recently, The American Lawyer Industry Awards named Moderna and Goodwin the Best Client-Law Firm Team – a relationship led by Cable.

In addition to advising Citrix, Haddad and Cable have led a number of groundbreaking deals. Among them, they previously advised MyoKardia, Inc. in its acquisition by Bristol Myers Squibb for $13.1 billion, Ritchie Bros. Incorporated on its acquisition by IAA, Inc. in a transaction valued at approximately $7.3 billion, Mimecast Limited in its $5.8 billion acquisition by Permira, and Spark Therapeutics on its $4.8 billion acquisition by Roche.

Beyond their practice, Haddad and Cable serve as the co-directors of Goodwin’s annual Directors Forum, which was founded in 2006, and grown to become a leading educational summit designed specifically for Directors of Goodwin’s public company clients. They are also the founders and leaders behind GOOD Directors, a first-of-its-kind evergreen ecosystem designed to create opportunities for next-generation, BIPOC, LGBTQ+ and women leaders to join Boards of Directors of public companies.